本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Can-Fite Biopharma Ltd

1.21
+0.01040.87%
成交量:19.01万
成交额:23.24万
市值:1,555.74万
市盈率:-1.11
高:1.24
开:1.23
低:1.21
收:1.20
数据加载中...
2019/03/11

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/04

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/02/25

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/02/04

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/02/01

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/01/30

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/01/24

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/01/24

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/01/22

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/01/18

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/01/08

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/10

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/10

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/06

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/03

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/11/30

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/11/20

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/10/31

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/10/25

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/10/25

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]